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ABSTRACT
Objective ageing is accompanied by deterioration 
of multiple bodily functions and inflammation, which 
collectively contribute to frailty. We and others have 
shown that frailty co- varies with alterations in the gut 
microbiota in a manner accelerated by consumption 
of a restricted diversity diet. The Mediterranean diet 
(MedDiet) is associated with health. in the nU- 
age project, we investigated if a 1- year MedDiet 
intervention could alter the gut microbiota and reduce 
frailty.
Design We profiled the gut microbiota in 612 non- frail 
or pre- frail subjects across five european countries 
(UK, France, netherlands, italy and Poland) before and 
after the administration of a 12- month long MedDiet 
intervention tailored to elderly subjects (nU- age diet).
Results adherence to the diet was associated with 
specific microbiome alterations. Taxa enriched by 
adherence to the diet were positively associated with 
several markers of lower frailty and improved cognitive 
function, and negatively associated with inflammatory 
markers including c- reactive protein and interleukin-17. 
analysis of the inferred microbial metabolite profiles 
indicated that the diet- modulated microbiome change 
was associated with an increase in short/branch chained 
fatty acid production and lower production of secondary 
bile acids, p- cresols, ethanol and carbon dioxide. 
Microbiome ecosystem network analysis showed that the 
bacterial taxa that responded positively to the MedDiet 
intervention occupy keystone interaction positions, 
whereas frailty- associated taxa are peripheral in the 
networks.
Conclusion collectively, our findings support the 
feasibility of improving the habitual diet to modulate 
the gut microbiota which in turn has the potential to 
promote healthier ageing.
Significance of this study
What is already known about this subject?
 ► Ageing is associated with deterioration of 
multiple bodily functions and inflammation, 
leading to the onset of frailty.
 ► The onset of frailty is associated with changes 
in the gut microbiota that are linked with a 
restricted diversity diet.
 ► The Mediterranean dietary regime is positively 
associated with health.
What are the new findings?
 ► Adherence to the Mediterranean diet led to 
increased abundance of specific taxa that were 
positively associated with several markers of 
lower frailty and improved cognitive function, 
and negatively associated with inflammatory 
markers including C- reactive protein and 
interleukin-17.
 ► These associations were independent of host 
factors such as age and body mass index.
 ► Inferred microbial metabolite profiling indicated 
that the diet- modulated microbiome change 
was associated with an increase in short/
branch chained fatty acid production and lower 
production of secondary bile acids, p- cresols, 
ethanol and carbon dioxide.
 ► Microbiome ecosystem network analysis 
showed that the bacterial taxa enriched due 
to the MedDiet intervention occupy keystone 
interaction positions, whereas frailty- associated 
taxa are peripheral in the networks.
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Significance of this study
How might it impact on clinical practice in the foreseeable 
future?
 ► Our findings support the feasibility of changing the habitual 
diet to modulate the gut microbiota which in turn has the 
potential to promote healthier ageing.
 ► Our findings also provide a short list of candidate taxa that 
can be investigated further as live biotherapeutic agents for 
direct administration to older subjects to reduce the onset of 
frailty.
INTRODuCTION
Frailty that accompanies ageing involves failure of multiple 
physiological systems1 and a persistent activation of the innate 
immune inflammatory response.2 Frailty may include the 
development of chronic low- grade inflammation (ie, inflamm- 
ageing),3 loss of cognitive function,4 sarcopenia5 and the devel-
opment of chronic diseases like diabetes and atherosclerosis.3 
Modification of dietary patterns such as adopting a Mediterra-
nean diet (MedDiet) has been suggested as a major therapeutic 
strategy to address frailty.6 The MedDiet regimen is character-
ised by increased consumption of vegetables, legumes, fruits, 
nuts, olive oil and fish and low consumption of red meat and 
dairy products and saturated fats.7 Adherence to a MedDiet is 
associated with reduced mortality, increased antioxidant activity, 
reduced incidences of several diseases, as well as reduced inflam-
mation.8 Several studies have shown that increased adherence to 
the MedDiet is linked to reduced frailty.9 Beyond the negative 
association with disease, higher level adherence to the MedDiet 
has been associated with beneficial changes in gut microbiome 
composition, with reduction in proteobacterial abundance 
accompanied by increased levels of short chain fatty acid 
production.10 11 On a global basis, the majority of elderly people 
do not consume a MedDiet and, in fact, a major challenge in 
elderly healthcare is the consumption of a restricted diet which 
is associated with a low- diversity gut microbiome, especially in 
subjects in long- term residential care.12 13 In previous work we 
have used fine detail bioinformatic (bi- clustering) analysis to 
identify specific microbial taxa that are lost in incremental stages 
in the transition from high- diversity microbiome healthy subjects 
to low- diversity frail subjects.14 In a recently completed 6- month 
dietary intervention in which elderly individuals were supple-
mented with up to 20 g daily of five prebiotics, multiple gut 
microbial taxa responded to the prebiotic supplementation,15 
but there was no change in overall microbiota alpha diversity 
and trends towards a reduction of inflammatory markers did 
not reach overall statistical significance. We thus reasoned that a 
more dramatic dietary intervention was required.
The NU- AGE dietary intervention project aimed to study the 
effect of the administration of a customised MedDiet for 12 
months in a large cohort of more than 1200 elderly individuals 
aged 65–79 years,16 distributed across five different countries 
(Poland, Netherlands, UK, France and Italy). Baseline and post- 
intervention results from this study have reported gender- and 
country- specific differences for measured metabolite levels as 
well as body composition data. A significant association was 
observed between increased adherence to the NU- AGE MedDiet 
and enhanced global cognitive ability and episodic memory.17 
Moreover, higher adherence has been shown to reduce the rate 
of bone loss in individuals with osteoporosis18 and to improve 
innate immune function,19 blood pressure and arterial stiffness.20 
In the current study we have profiled the effect of the NU- AGE 
MedDiet on the gut microbial community of a subset of partic-
ipants from the NU- AGE trial comprising 612 individuals (289 
controls (145 men and 144 women) and 323 with the NU- AGE 
MedDiet (141 men and 182 women)). A variety of beneficial 
outcomes were correlated to microbiome alterations.
MeTHODS
Study participants and dietary intervention
The NU- AGE study is a 1- year, randomised, multicentre, 
single- blind, controlled trial (registered with  clinicaltrials. gov, 
NCT01754012). Details on the recruitment of participants and 
the dietary intervention and the collection of metadata corre-
sponding to anthropometry, frailty and cognitive response have 
been previously described.17 21 Online supplementary table 
1 provides descriptive statistics of participants by country for 
whom paired microbiome profiles at baseline and the final time 
point were available.
Measurement of inflammatory and adiposity related 
hormones
Methods for the measurements of inflammatory markers have 
been previously described.22 Online supplementary text 1 briefly 
summarises the techniques used for this purpose.
DNA extraction and 16S rRNA gene sequencing
Microbial DNA was extracted from stool samples using the 
repeated bead beating method as previously described,23 with 
some modifications.24 The detailed protocol adopted for the 
DNA and 16S rRNA gene sequencing is described in online 
supplementary text 2.
Bioinformatic and biostatistical analysis
Online supplementary text 3 provides a complete description 
of the methodology used for the bioinformatics and the multi-
variate statistical analysis of the amplicon sequence data. This 
includes preprocessing of sequenced reads,25 identification of 
and removal of chimaeras,26 27 taxonomic classification of Oper-
ational Taxonomic Units (OTUs),28 29 machine learning- based 
identification of microbiome taxa associated with the dietary 
intervention30 (described in online supplementary figure 1), 
identification of taxonomic modules using the iterative Binary 
Bi- clustering of Gene- sets (iBBiG) approach,31 association anal-
ysis of dietary adherence and diet- associated taxonomic markers 
with the various components of diet as well as with the markers 
of frailty and inflammation, computation of MedDiet- associated 
microbiome indices (described pictorially in online supplemen-
tary figure 2) and the association analysis of these indices with 
dietary components, inflammation and frailty, obtaining inferred 
metabolite profiles based on per- sample species abundances 
and previously curated mappings of experimentally validated 
species- to- metabolite links32 33 and generation and visualisa-
tion of co- occurrence networks and computation of centrality 
measures (see online supplementary text 3).30 34
ReSulTS
Diet and microbiome profiles co-vary and differ between 
countries at baseline
Overall, there were 612 individuals (across the control and 
intervention cohorts) for whom paired microbiome data were 
collected at both the baseline and 1 year (referred to as ‘final’) 
time points. While the age ranges of the individuals in the control 
and intervention cohorts across countries were similar, there was 
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Figure 1 Baseline habitual diet and microbiota composition separate and co- vary by country, and the dietary intervention altered macronutrient 
profiles. Principal component analysis (PCoA) plots of (A) baseline dietary profiles and (B) baseline 16S microbiome profiles across the five different 
countries. For both, the PERMANOVA p values showing the significance of the association with the countries are also indicated. For the association 
between the dietary frequencies, the microbiome profiles, R2 and the significance values obtained using the Procrustes analysis are also shown. The 
results indicate that there are country- specific patterns in dietary habits which are also reflected in the microbiome profiles. (C) PCoA plots showing 
the distinct variations in the dietary patterns in the intervention and control cohorts. The PERMANOVA p values of these differences are also indicated. 
This reflects the effect of the dietary intervention to detect the specific dietary components driving these effects. Associations were computed between 
the intake frequencies of the components and the two PCoA axes (PCoA1 and PCoA2). These associations are plotted in (D). While the intervention 
group is primarily driven by an increase in consumption of fibres, vitamins (C, B6, B9, thiamine) and minerals (Cu, K, Fe, Mn, Mg), the changes in 
controls are associated with an increase in fats consumption.
a marginally higher representation of women in the interven-
tion cohort (Fisher's test p<0.12; online supplementary table 
1). Principal coordinate analysis (PCoA) indicated significant 
dietary differences at baseline between the countries showing 
three distinct subgroups (figure 1A) (PERMANOVA p<0.001: 
R2=0.33): the first containing Italian subjects; the second 
containing UK and French subjects; and the third containing 
those from the Netherlands and Poland. This specific pattern 
of clustering was also observed at the level of PCoA (based on 
Spearman distances) using the 16S rDNA OTU profiles at base-
line (figure 1B) (significant: PERMANOVA p<0.001; although 
with considerable overlaps: R2=0.036). While the Italian 
subjects had a distinct microbiome composition, those from 
UK/France and Poland/Netherlands were more like each other. 
Procrustes analysis of the food consumption and the OTU abun-
dance profiles confirmed a significant association between diet 
and microbiome composition (figure 1A,B; online supplemen-
tary figure 3; Procrustes RV coefficient 0.23; p<0.001). Specific 
microbiome components drove country- specific separations at 
baseline (Mann–Whitney test FDR- corrected p<0.15; online 
supplementary figure 4A–B). As expected, the dietary varia-
tions within the intervention group were significantly different 
from the control group (envfit p<0.006) (figure 1C). These 
changes in the intervention group were primarily driven by an 
increase in the intake of fibres, vitamins (C, B6, B9, thiamine) 
and minerals (Cu, K, Fe, Mn, Mg), while changes in the controls 
were associated with an increase in fat intake (saturated fats and 
mono- unsaturated fatty acids) relative to the MedDiet interven-
tion group (figure 1D).
Increasing adherence to the Nu-AGe MedDiet influences 
specific components of the gut microbiome previously 
associated with health
There were no significant changes in the global gut microbiota 
diversity in the subjects from individual countries in the inter-
vention and control groups (online supplementary figure 5). 
However, we observed that, across the study, increasing adher-
ence to the diet was associated with an attenuated loss of micro-
biome diversity (table 1). For a finer detailed microbiota–diet 
association analysis, we used adherence scores to the MedDiet, 
previously calculated based on the NU- AGE Food Based Dietary 
Guidelines (FBDG).35 These are recommendations that act 
as the basis for facilitating or measuring adherence to healthy 
eating initiatives or dietary interventions for improving public 
health. The NU- AGE FBDG covered 15 dietary goals including 
a vitamin D supplement that has been described in detail by 
Berendsen et al.35 We created Random Forest (RF) models to 
predict dietary adherence from microbiome profiles at both the 
baseline and final (1- year) time points. For both models, the 
correlations observed between the predicted food score (using 
the Random Forest model) and the actual food score were signif-
icant (baseline: R=0.27; p<1.2e-11; final: R=0.30; p<2.2e-14) 
(online supplementary figure 6A,B), indicating that there was 
a clear association between the microbiome and adherence to 
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Table 1 High adherence to a MedDiet attenuates the loss of diversity of the gut microbiome
low adherence Medium adherence High adherence
estimate
Standard 
error Z value P value estimate
Standard 
error Z value P value estimate
Standard 
error Z value P value
Intercept 387.11 113.53 3.41 0.00065*** 283.04 117.05 2.42 0.016* 412.97 97.48 4.24 2.3e-5**
Time point −9.51 4.85 −1.96 0.049* −9.34 4.99 −1.87 0.061(.) −3.84 4.93 −0.78 0.44
Gender -2 12.34 −0.16 0.87 16.97 12.62 1.34 0.179 −7.40 10.93 −0.68 0.5
Age −0.19 1.57 −0.12 0.90 1.21 1.64 0.74 0.46 −0.54 1.37 −0.39 0.69
A significant decline in diversity was observed across the time points in the low adherence group (as indicated in the estimate value).
Data tabulated are from regression analysis of the change in gut microbial diversity across the time points (baseline vs final), taking age and gender as the confounders in the 
three adherence change groups.
The decline attenuated from being marginally significant in the medium adherence group to non- significant in the high adherence group. Please refer to the Methods section for 
the definition of ‘low’, ‘medium’ and ‘high’ adherence groups of individuals.
The notations used for the p- values of significance are **P < 0.01; *P < 0.05 and; ***P < 0.10
Figure 2 Identification of diet responsive taxa by machine learning. (A) Correlation between the actual and predicted diet scores obtained 
using the random Forest approach. (B) Ranked feature importance scores of the top marker Operational Taxonomic Units (OTUs) responding 
positively and negatively to diet, along with their taxonomic affiliations (see Methods section for the selection of the top markers significantly 
associated with the food score). Top markers having a significant positive or negative association with diet scores were tagged as ‘DietPositive’ 
and ‘DietNegative’, respectively. The two groups show distinct taxonomic classifications. While DietPositive markers have an over- representation 
of species like Faecalibacterium prausnitzii, Eubacterium and Roseburia, DietNegative markers are characterised by the presence of Ruminococcus 
torques, Collinsella aerofaciens, Coprococcus comes, Dorea formicigenerans, Clostridium ramosum. The associations of the different groups with the 
adherence scores are also reflected in the changes across the time points between the intervention and control cohorts (as shown in C). (C) Boxplot 
showing the log- fold change in the gain/loss ratios of the various taxa (ie, the number of individuals in which a given OTU is increased divided by the 
number of individuals in which it is decreased across the time points) in the intervention cohorts compared with non- intervention in the two groups. 
While the DietPositive OTUs had a relatively positive increase in the intervention cohort (compared with the non- intervention group), changes in 
the DietNegative indicated a significant decrease with the intervention. (D) Boxplots showing the variation in the across time point changes in the 
DietPositive and the DietNegative OTUs in groups of individuals obtained after dividing them into three tertile groups (low, medium and high) based 
on increasing positive changes in adherence to the NU- AGE diet. The p values of the significance of the association are indicated as ****p<0.0001, 
***p<0.001, **p<0.01 and *p<0.05.
the MedDiet. For either time point, an optimal set of 75 OTUs 
provided the highest predictive performance (a total number 
of 129 OTUs combining both; see online supplementary figure 
6C,D) to identify the microbiome response to the MedDiet. We 
refer to these as 'diet- responsive' OTUs/taxa/markers throughout 
this study. Overall, using this optimal set of OTUs, the correla-
tion between the predicted and the observed adherence score 
was 0.39 (p<2.2 e-16) (figure 2A). The list of the top predictive 
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OTUs along with their taxonomic classification (obtained using 
SPINGO28) is provided in online supplementary table 2.
A total of 44 top predictive OTUs had a positive association 
with adherence scores (enriched with increasing adherence to 
diet) and 45 had a negative association (depleted with MedDiet 
adherence) (see Methods section). We refer to these as ‘Diet-
Positive’ and ‘DietNegative’ OTUs, respectively. A subset of 
these OTUs (with defined taxonomic classifications) along with 
their absolute feature importance scores is shown in figure 2B. 
The sets of taxa comprising these two groups are distinct. The 
DietPositive OTUs were mainly assigned to Faecalibacterium 
prausnitzii, along with Roseburia (R. hominis), Eubacterium (E. 
rectale, E. eligens, E. xylanophilum), Bacteroides thetaiotaomi-
cron, Prevotella copri and Anaerostipes hadrus. A majority of 
these taxa have previously reported positive health associations 
including production of short chain fatty acids (SCFAs) and anti- 
inflammatory properties as well as negative associations with 
diseases like type 2 diabetes and colorectal cancer.36–38 F. praus-
nitzii had also been negatively associated with frailty onset in the 
elderly.39 In contrast, the DietNegative OTUs mainly belonged 
to Ruminococcus torques, Collinsella aerofaciens, Coprococcus 
comes, Dorea formicigenerans, Clostridium ramosum, Veillonella 
dispar, Flavonifractor plautii and Actinomyces lingnae. Increase 
in the abundances of R. torques, C. aerofaciens, C. ramosum and 
V. dispar have been associated with type 2 diabetes and colorectal 
cancer, atherosclerosis, cirrhosis and inflammatory bowel 
disease.38 40–43 These findings collectively suggest that adherence 
to the MedDiet has the potential to modulate the microbiome in 
a direction positively associated with health.
Notably, in spite of country- specific microbiome composi-
tion differences at baseline (figure 1B; online supplementary 
figure 4A,B) and different dietary adherences (online supple-
mentary figure 7A) (as also reported by previous studies on 
this cohort),35 44 the diet- responsive taxa identified across the 
entire cohort were largely shared across the different nationali-
ties—that is, their association with diet was not specific for any 
country (see online supplementary text 4; online supplementary 
figure 4A,B; online supplementary figure 7). Their associations 
with MedDiet adherence were further validated by their pattern 
of abundance variation in both the intervention and control 
cohorts, as well as in individuals ranked by increasing adherence 
to the diet (see online supplementary text 5; online supplemen-
tary figure 8, figure 2C,D).
Next we investigated the co- occurring modules within the gut 
microbiomes. These modules are analogous to ‘guilds’ within the 
microbiomes that have similar or associated functional proper-
ties. We used iBBiG to identify modules in the gut microbiome,31 
an approach we previously used to identify granular differ-
ences in the microbiome as a function of healthy ageing in the 
ELDERMET cohort14 (see online supplementary text 3; online 
supplementary figure 9; online supplementary tables 3 and 4). 
iBBiG identified six overlapping taxonomic modules (named 
A to F) within the NU- AGE dataset. Notably, we identified a 
specific module C which was significantly over- abundant in indi-
viduals with increased frailty and also increased in representa-
tion in the set of DietNegative OTUs (see online supplementary 
text 6; online supplementary figure 9C,D). This indicates that 
module C is similar to the long- stay- like modules we identified 
in ELDERMET individuals.14 However, the specific enrichment 
of module C in the set of OTUs depleted with MedDiet adher-
ence indicated the likelihood that the MedDiet successfully 
modulated the gut microbiome in a manner negatively associated 
with frailty.
Adherence to the Nu-AGe MedDiet intervention modulated 
the microbiome in a manner negatively associated with 
frailty and inflammation
A major objective of the NU- AGE dietary intervention was 
reduction of frailty and inflamm- ageing. The study subjects were 
categorised into Non- Frail (or apparently healthy), Pre- Frail and 
Frail groups based on Fried scores.21 While the DietNegative 
taxa showed a stepwise significant decrease with the three frailty 
groupings (ie, Frail>Pre- Frail>Non- Frail), DietPositive taxa 
showed a significantly higher abundance in healthy (Non- Frail) 
individuals compared with Frail individuals (see online supple-
mentary figure 10A). The DietPositive taxa showed a signifi-
cantly positive change in individuals with reduced frailty (see 
online supplementary text 7; online supplementary figure 10B). 
During the intervention period, within the control cohort there 
was a marginally significant increase in the proportion of indi-
viduals with increased frailty (compared with the intervention 
group) (Fisher's test p<0.06; online supplementary figure 10C). 
However, we could not observe a direct association between 
dietary adherence scores and frailty (online supplementary 
figure 10D). We hypothesised that the effect of dietary adher-
ence on frailty could be indirect, whereby increasing adherence 
to a Mediterranean diet could modulate the microbiome (poten-
tially with some non- responders), and that this microbiome 
response could have a direct association with an attenuation of, 
or reduced risk of, frailty and improvements in other measures 
of well- being.
To investigate this, we computed the associations between 
the diet- responsive OTU markers and specific indices of frailty, 
cognitive function and inflammation across the entire study 
cohort (see online supplementary table 5 for list of metadata 
tested). The objective was to test if diet- responsive taxa showed 
significantly different trends of association with these indices 
(see online supplementary figure 11). Overall, although the 
absolute values of the associations were relatively weak, we 
observed significant differences in the association patterns of 
DietPositive and DietNegative OTUs for five different cyto-
kines/biomarkers (namely, pro- inflammatory high- sensitivity 
C reactive protein (hsCRP) and interleukin 17 (IL-17), anti- 
inflammatory sGP130 as well as adiponectin and leptin); three 
frailty- associated measures (Fried Score, Hand Grip Strength 
and Gait Speed Time); BabCock Memory Score and Construc-
tional Praxis (both associated with cognitive function). The most 
notable observation, however, was the pattern of these associ-
ations. The DietPositive OTU markers had consistent negative 
associations (significantly lower than the DietNegative markers) 
with the inflammatory markers hsCRP and IL-17 levels as well as 
with Fried Scores and Gait Speed Time (both measures associated 
with increased frailty) (figure 3A). In contrast, their associations 
were consistently positive with measures of improved cognitive 
function (eg, Constructional Praxis, BabCock Memory Score), 
reduced frailty (Hand Grip Strength) and two of the cytokines 
(adiponectin and sGP130) (a trend exactly opposite to that for 
DietNegative OTU markers). While the role of adiponectin as 
an anti- inflammatory marker is well documented,45 sGP130 is a 
negative regulator of the pro- inflammatory trans IL-6 signalling 
pathway.46 Notably, in spite of the country- specific variations in 
dietary intake, microbiome scores and adherence scores, each 
of these associations (with the exception of BabCock Memory 
Scores) could be replicated (both in terms of direction as well 
as the significance of the associations) in at least three of the 
countries (six of the 10 associations replicated in four of the 
five countries) (figure 3B). These results clearly indicate that 
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Figure 3 Consistent association of diet responsive taxa with different measures of frailty, cognitive function and inflammation. (A) Heatmap 
showing the variation of the association patterns (obtained using Spearman rhos) of the adherence associated marker Operational Taxonomic Units 
(OTUs) (arranged from top to bottom in increasing order of their correlations with the adherence scores) with the selected measures of frailty, 
cognitive function and the pro/anti- inflammatory cytokine levels. For each cell, colours indicate the Spearman rho values (as shown). **Significant 
association with FDR- corrected p value <0.15. *Marginal association with nominal p value <0.05. The DietPositive and DietNegative OTUs are also 
demarcated. Specific differences could be observed between the association pattern of the different measures and the DietPositive and DietNegative 
OTUs. For certain measures such as high- sensitivity C reactive protein (hsCRP) levels, interleukin 17 (IL-17) levels and gait speed time, DietPositive 
OTUs were observed to have significantly more negative correlations as compared to DietNegative OTUs. For the other measures associated with 
reduced frailty and improved cognitive function, as well as adiponectin and sGP130 levels, an exact opposite trend was observed. (B) Heat plot 
showing the replication of these trends individually within each of the country- specific cohorts. Brown indicates those cases where the correlations of 
the DietPositive OTUs were significantly more negative than the DietNegative group, green indicates those cases with the opposite trend and yellow 
indicates those cases of no significant change.
adherence to the NU- AGE MedDiet is associated with modu-
lation of the microbiome in a manner that is relatively consis-
tent (across the countries) and is in turn associated with reduced 
frailty, improved cognitive function and reduced inflammation.
Microbiome response, accompanied by specific beneficial 
changes in the gut metabolic profiles, is the key intermediate 
between dietary adherence and health
Based on the preceding findings, it seemed likely that a micro-
biome associated with dietary adherence was more important for 
improved health status than merely adherence to the diet itself. 
Testing this hypothesis required the computation of measurable 
‘microbiome scores/indices’ (analogous to the dietary adherence 
scores) that would take into account the variations associated with 
individual marker OTUs. Switching to the NU- AGE MedDiet is 
characterised by changes in the consumption pattern of specific 
dietary components—namely, an increase in the consumption 
of fibres (vegetables, fruits), carbohydrates (wholegrains), plant 
proteins (legumes), polyunsaturated fatty acids (fish) and vita-
mins such as vitamin C (fruits) and a concomitant decrease in 
the consumption of fats, alcohol, sodium and sugar (sweets).35 
We first validated the diet- responsive OTUs (identified based 
on their association with the overall NU- AGE FBDG scores) by 
checking their associations with the consumption patterns with 
the different food components (partial Spearman correlations 
taking into account age, body mass index, gender, country and 
polypharmacy as confounders). We observed that OTU markers 
with an increasing positive association with FBDG adher-
ence scores showed increasing positive correlations with fibre, 
vitamin C, vitamin D, plant proteins and carbohydrates and 
increasing negative associations with the components alcohol, 
fats and sugar whose consumption was decreased during the 
MedDiet change35 (see online supplementary figure 12). Thus, 
the above results indicate that the associations of the marker 
OTUs were not only with the overall FBDG scores, but also 
with individual dietary components whose modulations were 
associated with the NU- AGE MedDiet intervention (even after 
taking into account all host- associated confounding factors like 
age, body mass index, gender, country and polypharmacy). This 
validated the association of the dietary markers with the dietary 
intervention. Further, each of the diet- responsive OTUs had a 
specific degree of correlation with the dietary adherence scores 
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Figure 4 MedDiet microbiome index correlates with reduced frailty, improved cognitive function and reduced inflammation, independent of the 
adherence scores. Violin plot showing the association (partial Spearman correlations) of the different measures of frailty, cognitive function and 
inflammatory marker levels with the MedDiet- modulated microbiome index after taking into account the adherence scores as a confounder. The x 
axis shows the Spearman rho values and the y axis indicates the −log (base 10) of the p values. Most negatively associated measures are expected 
to be at the extreme left of the plot, the most positively associated measures are expected to be at the extreme right of the plot. Points are coloured 
based on the significance of the obtained associations (red indicates associations with FDR- corrected p<0.1, orange indicates associations with 
FDR- corrected p<0.2). The MedDiet microbiome index is observed to be associated with several measures associated with reduced frailty, reduced 
inflammation and improved cognitive function and this association is independent of the adherence scores.
and specific trends of association with the dietary components 
(see online supplementary figure 12). Based on the overall 
correlations of the diet- associated marker OTUs with the adher-
ence scores as well as the abundances marker OTUs in a given 
sample, we calculated a sample- specific diet- modulated micro-
biome index (see Methods section; online supplementary figure 
2). As expected, the microbiome index was positively correlated 
with the overall adherence scores and also captured the overall 
association patterns of the individual marker OTUs (ie, positive 
associations with fibre, carbohydrate, plant proteins, vitamin C, 
polyunsaturated fatty acids and negative associations with fats, 
alcohol and sugar), indicating its validity as a proxy for the taxo-
nomic markers associated with consumption of the MedDiet (see 
online supplementary figures 12,13; online supplementary text 
8).
We then checked the association of this index with the 
different measures of frailty, cognitive function and inflamma-
tion (across the entire cohort), considering the adherence scores 
as a confounder. Ten of the 11 associations with measures of 
improved cognition, reduced frailty and inflammation could be 
reproduced. We also observed additional negative associations 
with the inflammation- related cytokines interleukin (IL)-2 and 
macrophage inflammatory protein (MIP)- 1b, and positive asso-
ciations with verbal fluency (figure 4). These results show that 
the diet- modulated microbiome components are associated with 
frailty, inflammation and cognitive function independent of the 
adherence scores (ie, these are not indirect consequences of 
associations with dietary adherence). We had previously shown 
that these associations were stable across the different countries 
(figure 3B). We next checked the effect of confounders (such 
as age, body mass index, gender, disease pathophysiologies and 
medication intake) on the extent of diet–taxon associations. Indi-
viduals with multiple diseases, specifically those with diabetes, 
heart attack and inflammatory disorders, were observed to have 
significantly lower microbiome scores compared with non- 
diseased controls (lower but marginally significant for cancer) 
(see online supplementary figure 14A–E; online supplementary 
text 9; online supplementary table 6). However, the pattern 
of association of the microbiome index with seven of the 10 
inflammatory markers and frailty indices (identified in figure 4) 
largely remained invariant, even after taking into account all 
confounders including age, body mass index, gender, polyphar-
macy and different disease pathophysiologies (see online supple-
mentary text 9; online supplementary figure 15).
Even with respect to the across time point changes, while 
change in dietary adherence scores were significantly associated 
with change in the microbiome index, it was the change in the 
microbiome index that was positively associated with improve-
ment in cognitive function, physical well- being and negatively 
associated with inflammatory markers like hsCRP (see online 
supplementary text 10; online supplementary figure 16). Positive 
changes in microbiome indices were also associated with positive 
changes in the levels of the anti- inflammatory cytokine IL-10 
and negative changes in the ratio of hsCRP to anti- inflammatory 
cytokine levels, further indicating the negative association of the 
diet- associated microbiome index with inflammatory cytokine 
levels (see online supplementary figure 16C and online supple-
mentary text 10).
The positive influence of the diet- modulated microbiome 
change on health status is likely to be driven by specific microbial 
metabolites. Given that faecal metabolomic data were unavail-
able for the individuals, we predicted the functional metabolic 
profiles of the gut microbiome using the corresponding 16S 
species composition profiles (see Methods section). Correlating 
the across time point changes in the abundances of these 
predicted metabolic profiles with the microbiome index change 
identified dramatic differences across the microbiome response 
landscape (see online supplementary figure 17). A positive 
microbiome change was associated with an increase in the micro-
bial consumption of fibre- associated non- starch polysaccharides 
(probably indicative of Mediterranean diet change). In contrast, 
a negative change was associated with an increase in microbial 
simple sugar consumption. A negative microbiome response 
was also accompanied by a predicted increase in the microbial 
consumption of tauro- and glyco- derivatives of bile acids (such 
as taurocholate or glycochenodeoxycholate) to secondary bile 
acids (lithocholate, deoxycholate) through cholate and cheno-
deoxycholate (see online supplementary figure 18A). Bile acid 
dysregulation is associated with different disease conditions,47 
specifically the increase in production of lithocholic and 
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deoxycholic acid has been associated with colorectal cancer.48 
In contrast, increased production of both branched chain fatty 
acids (BCFAs) and SCFAs are associated with a positive micro-
biome response. A positive association of SCFAs with host health 
is well recognised.49 Previous studies measuring the metabolomic 
changes associated with intake of a MedDiet have also observed 
a similar increase in SCFA levels,10 50 as well as an exactly similar 
link wherein MedDiet- like dietary modulations (increased fibre 
intake and decreased fat intake) were observed to be positively 
associated with faecal SCFA levels and negatively associated with 
faecal secondary bile acids.51 52 Furthermore, in the current study 
we had data for the measured plasma levels of cholic acid (CA), 
glycochenodeoxycholic acid (GDCDA) and chenodeoxycholic 
acid (CDCA) for a subset of individuals belonging to the Italian 
and Polish cohorts. For GCDCA and CDCA, correlating the 
plasma levels of these bile acids with the abundances of the diet- 
associated markers revealed trends that the DietPositive OTUs 
had significantly more positive associations with GCDCA levels 
and more negative associations with CDCA levels compared 
with DietNegative OTUs (online supplementary figure 18B). 
By grouping this subset of individuals into three terciles based 
on their GDCDA/CDCA ratios, we observed that individuals 
with an increasing GCDCA/CDCA ratio were associated with a 
significantly positive change in their diet- associated microbiome 
index (online supplementary figure 18C). These results confirm 
the predicted metabolite profiles wherein individuals with 
increasing diet- associated microbiome indices were predicted 
to have decreased microbial conversion of GDCDA to CDCA 
(and thereafter to lithocholic acid (LCA) and deoxycholic acid 
(DCA)), thereby resulting in higher GDCDA/CDCA levels. Thus, 
some of the key global changes (in bile acid and SCFA levels) we 
detect and that we predicted to be linked with diet- associated 
microbiome response have been reported in the literature across 
multiple studies as well as the plasma level analysis. The only 
conflicting trend was with CA levels which were observed to 
show the pattern opposite to that expected. However, it could be 
because the measurements were on serum samples (in contrast to 
faecal levels) and CA/CDCA are produced by both the liver and 
the microbiota (see online supplementary figure 18C).
A negative microbiome response was also associated with other 
detrimental metabolites like p- cresol, ethanol and carbon dioxide, 
whose relative overproduction is associated with onset of colorectal 
cancer, insulin resistance, non- alcoholic fatty liver disease, cyto-
toxicity and small intestinal bacterial overgrowth.53–57 Notably, at 
baseline the diet- associated microbiome index was observed to be 
negatively associated with multiple diseases including hyperten-
sion, diabetes and cancer (online supplementary figure 14). Thus, 
although inferred rather than measured, the data indicate that 
metabolic change associated with a positive microbiome response 
beneficially impacts host health.
DietPositive OTus are keystone species in the gut microbial 
community
Finally, we evaluated the role of the diet- responsive taxa in 
the overall microbiome community structure, represented 
by networks defined by the Reboot Approach (see Methods 
section).30 A co- occurrence network provides a representation 
of nodes and edges (interconnecting lines) between these nodes, 
wherein the nodes represent the taxa (in this case, the OTUs) 
and the edges between the nodes represent a significant co- oc-
currence relationship between them (across a provided set of 
observations or samples). The placement of the taxa within a 
co- occurrence network indicates the relative importance of the 
taxa in the stability of the community. We first obtained the 
co- occurrence network for all the samples across time points 
for both cohorts. The major component of the co- occurrence 
network is a conglomeration of clusters of taxa, with other taxa 
acting as interlinking hubs. However, the positioning of the 
majority of DietPositive and DietNegative taxa was strikingly 
different. The DietPositive taxa were either located centrally at 
the hubs of the network or as linking nodes within the major 
subnodes (figure 5A). This shows the centrality of these taxa in 
the gut community structure, a phenomenon termed 'keystone 
species'.58 In contrast, the majority of the DietNegative taxa were 
placed at the periphery of the network. We probed this obser-
vation by computing two centrality measures for each taxon in 
the network: 'degree centrality', which is the number of nodes 
connected to a given node, and 'betweenness centrality', which is 
the number of paths connecting any two nodes that pass through 
a given node. DietPositive taxa had a significantly higher degree 
of betweenness centrality compared with the DietNegative taxa 
or the non- associated markers (figure 5B,C). We regenerated the 
network within each of the different countries as well as across 
overlapping windows of samples of increasing dietary adherence 
(see online supplementary figure 19; online supplementary figure 
20; online supplementary figure 21A). Despite major differences 
in the overall structure of the individual networks, the placement 
patterns of the taxa as well as their relative importance within 
the gut microbial networks were invariant irrespective of the 
country. The DietPositive taxa had significantly higher centrality 
measures irrespective of the nationality and the dietary adher-
ence of the individuals. As expected, there were also distinct 
patterns of interactions for the DietPositive and DietNegative 
groups of taxa, specifically with respect to the iBBiG identified 
frailty- associated module C, which had negative co- occurrence 
propensities with the DietPositive group (figure 5D). Interest-
ingly, the strength of the co- occurrence propensities became 
significantly more negative with increasing adherence to the diet 
(figure 5E). This was not observed for any of the other taxo-
nomic modules (see online supplementary figure 21B).
DISCuSSION
The current results provide a systemic view of the effect of 
consuming the NU- AGE MedDiet on the microbiome and subse-
quently on biomarkers of health in the elderly. A significant chal-
lenge for the current study was the high level of microbiome 
variability across individuals in five countries, resulting in a 
low signal- to- noise ratio which translated to weaker taxonomic 
signals for association with metadata. Analysis using traditional 
methodologies are useful and provide statistical rigour, even if 
the assumption of independent variables is not a true reflection 
of the community structure in the microbiota. However, due to 
the multitude and disparate nature of the microbiota structure 
configurations across individuals, combined with the relatively 
small effect of diet over a year of life in an established gut micro-
biota community as well as other aspects such as the subjec-
tive nature of the dietary measurements that is expected for 
community- dwelling individuals and the assumption that dietary 
measurements accurately measure the actual dietary change, the 
traditional statistical methodologies are unable to identify the 
taxa associated with the statistically significantly lower loss of 
diversity associated with adherence to the MedDiet. To establish 
the diet- responsive taxa and generate a diet- associated micro-
biome index, we applied a novel leave- one- out- cross- validation 
machine- learning methodology to predict the adherence score 
for each individual with good accuracy and used these predictive 
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Figure 5 Bacterial taxa that respond positively to Mediterranean diet intervention occupy keystone interaction nodes for peripheral frailty- 
associated taxa in microbiome networks. (A) Representation of the Operational Taxonomic Unit (OTU) co- occurrence network obtained for all the 
samples across the time points and cohorts with the DietPositive, DietNegative and non- correlated OTUs shown in green, red and grey colours, 
respectively. The network shows two distinct characteristics of the DietPositive and DietNegative markers (or OTUs). While the DietNegative markers 
(barring a few exceptions) are observed to occur as the peripheral nodes in the network, the DietPositive markers mostly act as either the centrally 
connected hub nodes or as interconnecting nodes between the hubs, indicating their centrality to the microbiome. This is also reflected in the 
comparison of the degree and betweenness centrality measures shown as boxplots in (B) and (C), respectively. (D) Relative co- occurrence propensity 
(calculated as the logged ratio of the number of positive edges to the number of negative edges) between the DietPositive and DietNegative OTUs 
with those belonging to the different iterative Binary Bi- clustering of Gene- sets (iBBiG) modules. It was observed that, specifically for the frailty- 
associated longstay- like module C, while the DietNegative markers showed a positive co- occurrence, the DietPositive markers showed a negative 
association, further indicating that taxa that respond positively to the diet negatively associate with those that are associated with frailty. (E) The 
negative association was further investigated by building networks for the five overlapping windows of samples W1–W5 (see Methods section), with 
increasing adherence to the diet. Relative co- occurrence propensity between the DietPositive and the module C across networks obtained for the 
overlapping windows of samples with increasing adherence to the diet. With increasing adherence to the diet, the relative co- occurrence propensity 
between the DietPositive OTUs and those belonging to the module C becomes increasingly negative. The p values of the significance of association 
are indicated as ****p<0.0001, ***p<0.001, **p<0.01, *p<0.05.
models to probe and identify the specific taxonomic signals that 
best predict increased adherence to the MedDiet.
We observed that increased adherence to the MedDiet 
modulates specific components of the gut microbiota that 
were associated with a reduction in risk of frailty, improved 
cognitive function and reduced inflammatory status. For 
reasons described above, these associations for some of the 
diet- modulated microbiome markers could only be observed 
at relatively weaker thresholds (rho <−0.09 and rho >0.07, 
FDR- corrected p values <0.2). This allowed for the visual-
isation and re- examination of the most predictive OTUs. 
However, the striking observation was the consistency of 
associations of the diet- modulated microbiome markers with 
biological markers of ageing (independent of nationality). The 
formulation and calculation of a single sample- specific micro-
biome index clarified these associations even further. For a 
single sample, this index provided a quantitative summary of 
the abundance patterns of the diet- responsive markers (the 
higher the value, the higher the abundance of DietPositive 
taxa and vice versa), thereby addressing the sample- specific 
variability associated with the individual markers. We showed 
that they were not only associated with dietary compliance 
but were consistently associated with frailty and inflammatory 
markers, thereby confirming their importance for health main-
tenance independent of other anthropometric confounders 
like age, body mass index and gender. In fact, the apparent 
lack of a direct link of the adherence score with frailty further 
hints that the response of an individual to the diet could be 
mediated by the change in the microbiome. Besides these 
associations, the keystone nature of the DietPositive markers 
within the gut microbiome remains remarkably stable across 
multiple nationalities. These keystone properties of the Diet-
Positive markers add support to the so- called Anna Karenina 
principle59 of microbiomes which posits that microbiomes of 
healthy individuals are similar and the unhealthy individuals 
are each aberrant in their own way. By protecting the ‘core’ 
of the gut microbial community, adherence to the diet could 
facilitate the retention of a stable community state in the 
microbiome, providing resilience and protecting from changes 
to alternative states that are found in unhealthy subjects.
The positive impact of these microbial taxa on host health 
was further indicated by predictive metabolite profiling, where 
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increasing adherence to the diet specifically selects for taxa 
that are enriched in the production of SCFAs/BCFAs, while 
selecting against those associated with bile acid dysregula-
tion and production of proposed deleterious metabolites like 
acetone, p- cresol, ethanol and carbon dioxide. Although this 
is an in- silico prediction, an increase of SCFA production 
with MedDiet consumption (or with specific components of 
the MedDiet) has been previously shown.10 50–52 The study by 
Pagliai et al, which compared the microbiome and metabo-
lome changes on MedDiet and vegetarian diets, reported a 
significant positive association of carbohydrate consump-
tion (which is increased in the MedDiet) with faecal levels 
of SCFA butyrate and a significant negative association of 
lipid and fat intake (decreased in the MedDiet) with levels 
of the SCFAs propionate and acetate. Negative associations 
of the SCFAs were also observed with levels of the inflam-
matory cytokine IL-17.50 Although the study by Pagliai et al 
observed no significant differences in the levels of BCFAs on 
the MedDiet (in contrast to the in- silico predictive metabolite 
analysis performed in our current study), a negative associ-
ation of the BCFA levels with fat intake was also observed 
(in line with our current findings). The links between the 
MedDiet- associated microbiome modulation, SCFA produc-
tion and the carcinogenic secondary bile acid production are 
precisely in line with findings from two previous studies on 
African Americans and rural Africans.51 52 Interestingly, across 
the secondary bile acid production landscape, while the faecal 
metabolome results from the study by O’Keefe et al confirmed 
the predicted metabolite changes with respect to CA and the 
carcinogenic secondary bile acids DCA and LCA, the plasma 
metabolite levels (in the current study) confirm the predicted 
changes with respect to CDCA and GCDCA (although plasma 
metabolite levels are not expected to exactly reflect the faecal 
metabolome). Thus, results obtained from these studies largely 
complement each other and resonate with our current find-
ings, and the predicted downregulation of the other poten-
tially detrimental metabolite production provides an informed 
list of candidate compounds that can be further verified by 
targeted metabolomic profiling in future studies.
The interplay of diet, microbiome and host health is a complex 
phenomenon influenced by several factors. It is also probably a 
multistep process dictated by specific mechanistic rules. While 
the results of this study shed light on some of the rules of this 
three- way interplay, several factors such as age, body mass index, 
disease status and initial dietary patterns may play a key role in 
determining the extent of success of these interactions. Interest-
ingly, the beneficial effects of MedDiet intervention mediated 
through the microbiome are not restricted to elderly subjects, as 
evidenced by the study by Meslier et al60 (this volume; co- sub-
mitted to Gut for back- to- back publication) showing that a similar 
intervention in obese subjects resulted in multiple health- related 
shifts in the gut microbiome and metabolome independently of 
energy intake. Notwithstanding this theoretical and practical 
reinforcement, the strategy of promoting health in the elderly 
by maintaining a long- term MedDiet (or supplementation of 
specific ingredients) may be impractically expensive or logisti-
cally impossible in many countries where these ingredients are 
neither staple nor available year- round. In some older subjects 
with problems like dentition, saliva production, dysphagia or 
irritable bowel syndrome, adapting a MedDiet may not be a 
realistic option. Our definition here of MedDiet- responsive taxa 
that correlate with health, plus our recent identification of taxa 
associated with healthy ageing in a large metacohort of 2500 
subjects,61 provides a short list of candidate taxa for development 
as live biotherapeutic agents for direct administration to older 
subjects to reduce onset of frailty.
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